In the TME and cancer-bearing hosts, the functional capacity of cancer-specific effector CD8+ T cells was compromised by the expression of several negative immune checkpoint molecules on their surfaces, which led to their exhaustion [8,9]. The gene discussed is CD8A; the disease is cancer.